Global Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Route of Administration, Drug Type, and Region: Trend Forecast and Growth Opportunity

August 2020 | 182 pages | ID: G7DC25BCF2D0EN
GMD Research

Abstracts

Global antibiotics market will reach $63.99 billion by 2030, growing by 3.5% annually over 2020-2030 driven by rising incidences of bacterial infection, growing awareness and need for new drugs and treatment amid the COVID-19 epidemic.

Highlighted with 86 tables and 93 figures, this 182-page report “Global Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Route of Administration, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global antibiotics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global antibiotics market in every aspect of the classification from perspectives of Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Route of Administration, Drug Type, and Region.

Based on Drug Class, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Cephalosporin
• Penicillin
• Macrolides
• Fluoroquinolones
• Quinolones
• Monobactam
• Aminoglycosides
• Carbapenem
• Other Drug Classes

Based on Action Mechanism, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Cell Wall Synthesis Inhibitors
• Mycolic Acid Inhibitors
• RNA Synthesis Inhibitors
• DNA Synthesis Inhibitors
• Protein Synthesis Inhibitors
• Other Mechanisms

Based on Drug Origin, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Natural Antibiotics
• Semi-synthetic Antibiotics
• Synthetic Antibiotics

Based on Activity Spectrum, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Broad-spectrum Antibiotics
• Narrow-spectrum Antibiotics

Based on Route of Administration, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Oral Administration
• Intravenous Administration
• Other Administration Routes

Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Brand Antibiotics
• Generic Antibiotics

Geographically, the following regions together with the listed national/local markets are fully investigated:

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• RoW (Saudi Arabia, UAE, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Drug Class, Drug Origin, and Route of Administration over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global antibiotics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
Astellas Pharma
AstraZeneca Plc
Bayer AG
Bristol Myers Squibb Company
Cipla Inc.
Dr. Reddy’s Laboratories Ltd.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)
Mayne Pharma Group Ltd.
MELINTA THERAPEUTICS, INC.
Merck KGaA
Novartis AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY DRUG CLASS

3.1 Market Overview by Drug Class
3.2 Cephalosporin
3.3 Penicillin
3.4 Macrolides
3.5 Fluoroquinolones
3.6 Quinolones
3.7 Monobactam
3.8 Aminoglycosides
3.9 Carbapenem
3.10 Other Drug Classes

4 SEGMENTATION OF GLOBAL MARKET BY ACTION MECHANISM

4.1 Market Overview by Action Mechanism
4.2 Cell Wall Synthesis Inhibitors
4.3 Mycolic Acid Inhibitors
4.4 RNA Synthesis Inhibitors
4.5 DNA Synthesis Inhibitors
4.6 Protein Synthesis Inhibitors
4.7 Other Mechanisms

5 SEGMENTATION OF GLOBAL MARKET BY DRUG ORIGIN

5.1 Market Overview by Drug Origin
5.2 Natural Antibiotics
5.3 Semi-synthetic Antibiotics
5.4 Synthetic Antibiotics

6 SEGMENTATION OF GLOBAL MARKET BY ACTIVITY SPECTRUM

6.1 Market Overview by Activity Spectrum
6.2 Broad-spectrum Antibiotics
6.3 Narrow-spectrum Antibiotics

7 SEGMENTATION OF GLOBAL MARKET BY ROUTE OF ADMINISTRATION

7.1 Market Overview by Route of Administration
7.2 Oral Administration
7.3 Intravenous Administration
7.4 Other Administration Routes

8 SEGMENTATION OF GLOBAL MARKET BY DRUG TYPE

8.1 Market Overview by Drug Type
8.2 Brand Antibiotics
8.3 Generic Antibiotics

9 SEGMENTATION OF GLOBAL MARKET BY REGION

9.1 Geographic Market Overview 2019-2030
9.2 North America Market 2019-2030 by Country
  9.2.1 Overview of North America Market
  9.2.2 U.S.
  9.2.3 Canada
  9.2.4 Mexico
9.3 European Market 2019-2030 by Country
  9.3.1 Overview of European Market
  9.3.2 Germany
  9.3.3 UK
  9.3.4 France
  9.3.5 Spain
  9.3.6 Italy
  9.3.7 Russia
  9.3.8 Rest of European Market
9.4 Asia-Pacific Market 2019-2030 by Country
  9.4.1 Overview of Asia-Pacific Market
  9.4.2 Japan
  9.4.3 China
  9.4.4 Australia
  9.4.5 India
  9.4.6 South Korea
  9.4.7 Rest of APAC Region
9.5 South America Market 2019-2030 by Country
  9.5.1 Argentina
  9.5.2 Brazil
  9.5.3 Chile
  9.5.4 Rest of South America Market
9.6 MEA Market 2019-2030 by Country
  9.6.1 UAE
  9.6.2 Saudi Arabia
  9.6.3 South Africa
  9.6.4 Other National Markets

10 COMPETITIVE LANDSCAPE

10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
Abbott Laboratories
Astellas Pharma
AstraZeneca Plc
Bayer AG
Bristol Myers Squibb Company
Cipla Inc.
Dr. Reddy’s Laboratories Ltd.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)
Mayne Pharma Group Ltd.
MELINTA THERAPEUTICS, INC.
Merck KGaA
Novartis AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.

11 INVESTING IN GLOBAL MARKET: RISK ASSESSMENT AND MANAGEMENT

11.1 Risk Evaluation of Global Market
11.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Global Antibiotics Market, 2019-2030
Table 2. Main Product Trends and Market Opportunities in Global Antibiotics Market
Table 3. Global Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 4. Global Antibiotics Market by Action Mechanism, 2019-2030, $ mn
Table 5. Global Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 6. Global Antibiotics Market by Activity Spectrum, 2019-2030, $ mn
Table 7. Global Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 8. Global Antibiotics Market by Drug Type, 2019-2030, $ bn
Table 9. Global Antibiotics Market by Region, 2019-2030, $ bn
Table 10. Total Health Expenditure per capita in PPP International U.S. Dollars by Country
Table 11. Leading National Antibiotics Market, 2019 and 2030, $ bn
Table 12. North America Antibiotics Market by Country, 2019-2030, $ bn
Table 13. U.S. Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 14. U.S. Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 15. U.S. Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 16. Canada Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 17. Canada Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 18. Canada Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 19. Mexico Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 20. Mexico Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 21. Mexico Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 22. Europe Antibiotics Market by Country, 2019-2030, $ bn
Table 23. Germany Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 24. Germany Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 25. Germany Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 26. UK Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 27. UK Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 28. UK Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 29. France Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 30. France Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 31. France Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 32. Spain Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 33. Spain Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 34. Spain Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 35. Italy Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 36. Italy Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 37. Italy Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 38. Russia Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 39. Russia Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 40. Russia Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 41. Antibiotics Market in Rest of Europe by Country, 2019-2030, $ bn
Table 42. APAC Antibiotics Market by Country, 2019-2030, $ bn
Table 43. Japan Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 44. Japan Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 45. Japan Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 46. China Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 47. China Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 48. China Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 49. Australia Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 50. Australia Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 51. Australia Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 52. India Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 53. India Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 54. India Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 55. South Korea Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 56. South Korea Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 57. South Korea Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 58. Antibiotics Market in Rest of APAC by Country, 2019-2030, $ bn
Table 59. South America Antibiotics Market by Country, 2019-2030, $ bn
Table 60. Argentina Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 61. Argentina Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 62. Argentina Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 63. Brazil Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 64. Brazil Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 65. Brazil Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 66. Chile Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 67. Chile Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 68. Chile Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 69. MEA Antibiotics Market by Country, 2019-2030, $ bn
Table 70. UAE Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 71. UAE Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 72. UAE Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 73. Saudi Arabia Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 74. Saudi Arabia Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 75. Saudi Arabia Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 76. South Africa Antibiotics Market by Drug Class, 2019-2030, $ mn
Table 77. South Africa Antibiotics Market by Drug Origin, 2019-2030, $ mn
Table 78. South Africa Antibiotics Market by Route of Administration, 2019-2030, $ mn
Table 79. Breakdown of Global Market by Key Vendor, 2019, %
Table 80. Abbott Laboratories: Company Snapshot
Table 81. Abbott Laboratories: Business Segmentation
Table 82. Abbott Laboratories: Product Portfolio
Table 83. Abbott Laboratories: Revenue, 2016-2018, $ mn
Table 84. Abbott Laboratories: Recent Developments
Table 85. Risk Evaluation for Investing in Global Market, 2019-2030
Table 86. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Global Antibiotics Market, 2019-2030, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Antibiotics Market
Figure 8. GDP per capita in the World, 1960-2018, $ thousand
Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million
Figure 10. Primary Restraints and Impact Factors of Global Antibiotics Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Global Antibiotics Market
Figure 13. Breakdown of Global Antibiotics Market by Drug Class, 2019-2030, % of Revenue
Figure 14. Global Addressable Market Cap in 2020-2030 by Drug Class, Value ($ mn) and Share (%)
Figure 15. Global Antibiotics Market: Cephalosporin, 2019-2030, $ mn
Figure 16. Global Antibiotics Market: Penicillin, 2019-2030, $ mn
Figure 17. Global Antibiotics Market: Macrolides, 2019-2030, $ mn
Figure 18. Global Antibiotics Market: Fluoroquinolones, 2019-2030, $ mn
Figure 19. Global Antibiotics Market: Quinolones, 2019-2030, $ mn
Figure 20. Global Antibiotics Market: Monobactam, 2019-2030, $ mn
Figure 21. Global Antibiotics Market: Aminoglycosides, 2019-2030, $ mn
Figure 22. Global Antibiotics Market: Carbapenem, 2019-2030, $ mn
Figure 23. Global Antibiotics Market: Other Drug Classes, 2019-2030, $ mn
Figure 24. Breakdown of Global Antibiotics Market by Action Mechanism, 2019-2030, % of Sales Revenue
Figure 25. Global Addressable Market Cap in 2020-2030 by Action Mechanism, Value ($ mn) and Share (%)
Figure 26. Global Antibiotics Market: Cell Wall Synthesis Inhibitors, 2019-2030, $ mn
Figure 27. Global Antibiotics Market: Mycolic Acid Inhibitors, 2019-2030, $ mn
Figure 28. Global Antibiotics Market: RNA Synthesis Inhibitors, 2019-2030, $ mn
Figure 29. Global Antibiotics Market: DNA Synthesis Inhibitors, 2019-2030, $ mn
Figure 30. Global Antibiotics Market: Protein Synthesis Inhibitors, 2019-2030, $ mn
Figure 31. Global Antibiotics Market: Other Mechanisms, 2019-2030, $ mn
Figure 32. Breakdown of Global Antibiotics Market by Drug Origin, 2019-2030, % of Sales Revenue
Figure 33. Global Addressable Market Cap in 2020-2030 by Drug Origin, Value ($ mn) and Share (%)
Figure 34. Global Antibiotics Market: Natural Antibiotics, 2019-2030, $ mn
Figure 35. Global Antibiotics Market: Semi-synthetic Antibiotics, 2019-2030, $ mn
Figure 36. Global Antibiotics Market: Synthetic Antibiotics, 2019-2030, $ mn
Figure 37. Breakdown of Global Antibiotics Market by Activity Spectrum, 2019-2030, % of Revenue
Figure 38. Global Addressable Market Cap in 2020-2030 by Activity Spectrum, Value ($ mn) and Share (%)
Figure 39. Global Antibiotics Market: Broad-spectrum Antibiotics, 2019-2030, $ mn
Figure 40. Global Antibiotics Market: Narrow-spectrum Antibiotics, 2019-2030, $ mn
Figure 41. Breakdown of Global Antibiotics Market by Route of Administration, 2019-2030, % of Revenue
Figure 42. Global Addressable Market Cap in 2020-2030 by Route of Administration, Value ($ mn) and Share (%)
Figure 43. Global Antibiotics Market: Oral Administration, 2019-2030, $ mn
Figure 44. Global Antibiotics Market: Intravenous Administration, 2019-2030, $ mn
Figure 45. Global Antibiotics Market: Other Administration Routes, 2019-2030, $ mn
Figure 46. Breakdown of Global Antibiotics Market by Drug Type, 2019-2030, % of Revenue
Figure 47. Global Addressable Market Cap in 2020-2030 by Drug Type, Value ($ bn) and Share (%)
Figure 48. Global Antibiotics Market: Brand Antibiotics, 2019-2030, $ bn
Figure 49. Global Antibiotics Market: Generic Antibiotics, 2019-2030, $ bn
Figure 50. Global Market Snapshot by Region
Figure 51. Geographic Spread of Worldwide Antibiotics Market, 2019-2030, % of Sales Revenue
Figure 52. Global Addressable Market Cap in 2020-2030 by Region, Value ($ bn) and Share (%)
Figure 53. Health Spending as a Share of GDP by Country, 2015 and 2030
Figure 54. North American Antibiotics Market, 2019-2030, $ bn
Figure 55. Breakdown of North America Antibiotics Market by Country, 2019 and 2030, % of Revenue
Figure 56. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 57. U.S. Antibiotics Market, 2019-2030, $ bn
Figure 58. Rising Incidence of Infectious Disease in U.S.
Figure 59. Canada Antibiotics Market, 2019-2030, $ bn
Figure 60. Antibiotics Market in Mexico, 2015-2030, $ bn
Figure 61. European Antibiotics Market, 2019-2030, $ bn
Figure 62. Breakdown of European Antibiotics Market by Country, 2019 and 2030, % of Revenue
Figure 63. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 64. Antibiotics Market in Germany, 2019-2030, $ bn
Figure 65. Antibiotics Market in UK, 2019-2030, $ bn
Figure 66. Antibiotics Market in France, 2019-2030, $ bn
Figure 67. Antibiotics Market in Spain, 2019-2030, $ bn
Figure 68. Antibiotics Market in Italy, 2019-2030, $ bn
Figure 69. Antibiotics Market in Russia, 2019-2030, $ bn
Figure 70. Antibiotics Market in Rest of Europe, 2019-2030, $ bn
Figure 71. Asia-Pacific Antibiotics Market, 2019-2030, $ bn
Figure 72. Breakdown of APAC Antibiotics Market by Country, 2019 and 2030, % of Revenue
Figure 73. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 74. Antibiotics Market in Japan, 2019-2030, $ bn
Figure 75. Antibiotics Market in China, 2019-2030, $ bn
Figure 76. Antibiotics Market in Australia, 2019-2030, $ bn
Figure 77. Antibiotics Market in India, 2019-2030, $ bn
Figure 78. Antibiotics Market in South Korea, 2019-2030, $ bn
Figure 79. Antibiotics Market in Rest of APAC, 2019-2030, $ bn
Figure 80. South America Antibiotics Market, 2019-2030, $ bn
Figure 81. Breakdown of South America Antibiotics Market by Country, 2019 and 2030, % of Revenue
Figure 82. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 83. Antibiotics Market in Argentina, 2019-2030, $ bn
Figure 84. Antibiotics Market in Brazil, 2019-2030, $ bn
Figure 85. Antibiotics Market in Chile, 2019-2030, $ bn
Figure 86. Antibiotics Market in Rest of South America, 2019-2030, $ bn
Figure 87. Antibiotics Market in Middle East and Africa (MEA), 2019-2030, $ bn
Figure 88. Breakdown of MEA Antibiotics Market by Country, 2019 and 2030, % of Revenue
Figure 89. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 90. Antibiotics Market in UAE, 2019-2030, $ bn
Figure 91. Antibiotics Market in Saudi Arabia, 2019-2030, $ bn
Figure 92. Antibiotics Market in South Africa, 2019-2030, $ bn
Figure 93. Growth Stage of Global Antibiotics Industry over the Forecast Period

COMPANIES MENTIONED

Abbott Laboratories
Astellas Pharma
AstraZeneca Plc
Bayer AG
Bristol Myers Squibb Company
Cipla Inc.
Dr. Reddy’s Laboratories Ltd.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)
Mayne Pharma Group Ltd.
MELINTA THERAPEUTICS, INC.
Merck KGaA
Novartis AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.